189 related articles for article (PubMed ID: 10348780)
1. Rifampin and rifabutin resistance mechanism in Helicobacter pylori.
Heep M; Beck D; Bayerdörffer E; Lehn N
Antimicrob Agents Chemother; 1999 Jun; 43(6):1497-9. PubMed ID: 10348780
[TBL] [Abstract][Full Text] [Related]
2. Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany.
Glocker E; Bogdan C; Kist M
J Antimicrob Chemother; 2007 May; 59(5):874-9. PubMed ID: 17350989
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of Helicobacter pylori resistance to rifamycins.
Hays C; Burucoa C; Lehours P; Tran CT; Leleu A; Raymond J
Helicobacter; 2018 Feb; 23(1):. PubMed ID: 29168600
[TBL] [Abstract][Full Text] [Related]
4. Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori.
Suzuki S; Suzuki H; Nishizawa T; Kaneko F; Ootani S; Muraoka H; Saito Y; Kobayashi I; Hibi T
Digestion; 2009; 79(1):1-4. PubMed ID: 19142036
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of rifabutin-resistance in refractory Helicobacter pylori infection in Taiwan.
Kuo CJ; Bui NN; Ke JN; Lin CY; Lin WR; Chang ML; Wu HY; Huang MZ; Chiu CH; Chiu CT; Lai CH
Int J Infect Dis; 2024 Jan; 138():25-28. PubMed ID: 37956898
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis.
Heep M; Rieger U; Beck D; Lehn N
Antimicrob Agents Chemother; 2000 Apr; 44(4):1075-7. PubMed ID: 10722516
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
Cavusoglu C; Karaca-Derici Y; Bilgic A
Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882
[TBL] [Abstract][Full Text] [Related]
8. Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency.
Anthony RM; Schuitema AR; Bergval IL; Brown TJ; Oskam L; Klatser PR
Ann Clin Microbiol Antimicrob; 2005 Jun; 4():9. PubMed ID: 15958167
[TBL] [Abstract][Full Text] [Related]
9. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.
Yang B; Koga H; Ohno H; Ogawa K; Fukuda M; Hirakata Y; Maesaki S; Tomono K; Tashiro T; Kohno S
J Antimicrob Chemother; 1998 Nov; 42(5):621-8. PubMed ID: 9848446
[TBL] [Abstract][Full Text] [Related]
10. [Cross-resistance between rifampin and rifabutin in multidrug resistant Mycobacterium tuberculosis complex strains].
Gao L; Xiao HP; Hu ZY; Cui ZL; Lu JM; Shen XN
Zhonghua Jie He He Hu Xi Za Zhi; 2012 May; 35(5):333-5. PubMed ID: 22883990
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the antimycobacterial activities of rifabutin and the relationship between drug-resistance and rpoB mutations of Mycobacterium tuberculosis].
Han XQ; Huang HR; Li YJ; Yu X; Gao JT; Bi ZQ; Chu NH; Li L; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):762-5. PubMed ID: 22321711
[TBL] [Abstract][Full Text] [Related]
12. Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
Schön T; Juréen P; Chryssanthou E; Giske CG; Kahlmeter G; Hoffner S; Angeby K
J Antimicrob Chemother; 2013 Sep; 68(9):2074-7. PubMed ID: 23633684
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of rifabutin and rifampin against clinical isolates of Mycobacterium tuberculosis in Taiwan.
Chien HP; Yu MC; Ong TF; Lin TP; Luh KT
J Formos Med Assoc; 2000 May; 99(5):408-11. PubMed ID: 10870331
[TBL] [Abstract][Full Text] [Related]
14. Investigation of cross-resistance between rifampin and rifabutin in Mycobacterium tuberculosis complex strains.
Uzun M; Erturan Z; Anğ O
Int J Tuberc Lung Dis; 2002 Feb; 6(2):164-5. PubMed ID: 11931417
[TBL] [Abstract][Full Text] [Related]
15. Detection of rifabutin resistance and association of rpoB mutations with resistance to four rifamycin derivatives in Helicobacter pylori.
Heep M; Lehn N; Brandstätter B; Rieger U; Senzenberger S; Wehrl W
Eur J Clin Microbiol Infect Dis; 2002 Feb; 21(2):143-5. PubMed ID: 11939398
[No Abstract] [Full Text] [Related]
16. Helicobacter pylori resistance to rifabutin in the last 7 years.
Nishizawa T; Suzuki H; Matsuzaki J; Muraoka H; Tsugawa H; Hirata K; Hibi T
Antimicrob Agents Chemother; 2011 Nov; 55(11):5374-5. PubMed ID: 21896915
[TBL] [Abstract][Full Text] [Related]
17. Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.
Berrada ZL; Lin SY; Rodwell TC; Nguyen D; Schecter GF; Pham L; Janda JM; Elmaraachli W; Catanzaro A; Desmond E
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):177-81. PubMed ID: 27036978
[TBL] [Abstract][Full Text] [Related]
18. Mutations at four distinct regions of the rpoB gene can reduce the susceptibility of Helicobacter pylori to rifamycins.
Heep M; Odenbreit S; Beck D; Decker J; Prohaska E; Rieger U; Lehn N
Antimicrob Agents Chemother; 2000 Jun; 44(6):1713-5. PubMed ID: 10817737
[TBL] [Abstract][Full Text] [Related]
19. Rifampicin- and Rifabutin-Resistant Listeria monocytogenes Strains Isolated from Food Products Carry Mutations in rpoB Gene.
Korsak D; Krawczyk-Balska A
Foodborne Pathog Dis; 2016 Jul; 13(7):363-8. PubMed ID: 27105395
[TBL] [Abstract][Full Text] [Related]
20. Effective antimicrobial activity of rifabutin against multidrug-resistant Helicobacter pylori.
Siavoshi F; Saniee P; Malekzadeh R
Helicobacter; 2018 Dec; 23(6):e12531. PubMed ID: 30230637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
